These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28004138)

  • 61. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
    Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
    Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
    Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
    J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
    Intven M; Monninkhof EM; Reerink O; Philippens ME
    Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings.
    Suo ST; Chen XX; Fan Y; Wu LM; Yao QY; Cao MQ; Liu Q; Xu JR
    Acad Radiol; 2014 Aug; 21(8):1027-34. PubMed ID: 24833566
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging.
    Hu F; Tang W; Sun Y; Wan D; Cai S; Zhang Z; Grimm R; Yan X; Fu C; Tong T; Peng W
    Oncotarget; 2017 Sep; 8(43):75597-75606. PubMed ID: 29088894
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience.
    De Cecco CN; Ciolina M; Caruso D; Rengo M; Ganeshan B; Meinel FG; Musio D; De Felice F; Tombolini V; Laghi A
    Abdom Radiol (NY); 2016 Sep; 41(9):1728-35. PubMed ID: 27056748
    [TBL] [Abstract][Full Text] [Related]  

  • 69. mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer.
    Attenberger UI; Ong MM; Rathmann N; Doyon F; Kienle P; Hofheinz RD; Pilz LR; Dinter DJ; Schoenberg SO; Hausmann D
    Anticancer Res; 2017 Jan; 37(1):215-222. PubMed ID: 28011494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy.
    Hirata A; Hayano K; Ohira G; Imanishi S; Hanaoka T; Murakami K; Aoyagi T; Shuto K; Matsubara H
    Am J Surg; 2020 Jun; 219(6):1024-1029. PubMed ID: 31387687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.
    Bakke KM; Hole KH; Dueland S; Grøholt KK; Flatmark K; Ree AH; Seierstad T; Redalen KR
    Acta Oncol; 2017 Jun; 56(6):813-818. PubMed ID: 28464745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging.
    Kong LY; Zhang W; Zhou Y; Xu H; Shi HB; Feng Q; Xu XQ; Yu TF
    Br J Radiol; 2018 Apr; 91(1084):20170580. PubMed ID: 29260882
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.
    Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK
    Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
    Dinapoli N; Barbaro B; Gatta R; Chiloiro G; Casà C; Masciocchi C; Damiani A; Boldrini L; Gambacorta MA; Dezio M; Mattiucci GC; Balducci M; van Soest J; Dekker A; Lambin P; Fiorino C; Sini C; De Cobelli F; Di Muzio N; Gumina C; Passoni P; Manfredi R; Valentini V
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):765-774. PubMed ID: 29891200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Magnetic Resonance of Rectal Cancer Response to Therapy: An Image Quality Comparison between 3.0 and 1.5 Tesla.
    Caruso D; Zerunian M; De Santis D; Biondi T; Paolantonio P; Rengo M; Bellini D; Ferrari R; Ciolina M; Lucertini E; Polici M; Iannicelli E; Tombolini V; Laghi A
    Biomed Res Int; 2020; 2020():9842732. PubMed ID: 33102603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diffusion kurtosis imaging in identifying the malignancy of lymph nodes during the primary staging of rectal cancer.
    Yu J; Dai X; Zou HH; Song JC; Li Y; Shi HB; Xu Q; Shen H
    Colorectal Dis; 2018 Feb; 20(2):116-125. PubMed ID: 28772347
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Are ADC values of readout-segmented echo-planar diffusion-weighted imaging (RESOLVE) correlated with pathological prognostic factors in rectal adenocarcinoma?
    Tang C; Lin MB; Xu JL; Zhang LH; Zuo XM; Zhang ZS; Liu MX; Xu JM
    World J Surg Oncol; 2018 Jul; 16(1):138. PubMed ID: 30001205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.